Medicinehospital

Remdesivir

An antiviral infusion for treating COVID-19.

Clinical information

Common uses

COVID-19 in hospitalised patients
mild-to-moderate COVID-19 in people at high risk

Common side effects

feeling sick
raised liver enzymes

Cautions

allergic and infusion reactions can occur — monitored during infusion
liver tests needed before and during treatment

Interactions

chloroquine or hydroxychloroquine — not recommended; may reduce effect

Pregnancy: no increased risk seen later in pregnancy — limited first-trimester data

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Veklury (remdesivir) label, setid c0978fa8-53ff-4ca2-82a7-567fd3e958ca (accessed 2026-08-16)

Approved brands & formulations1

Brand name	Dosage form	Strength	Importer	Category
Remdesivir	Parenteral ( Infusion- Solution IV )	100mg /Vial (5mg/ml)	MFDA designated importers with Pre Authorization approval before import	hospital